Viewing StudyNCT00217555



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217555
Status: COMPLETED
Last Update Posted: 2010-09-21
First Post: 2005-09-20

Brief Title: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian Fallopian Tube or Primary Peritoneal Cavity Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Organization Data

Organization: Fred Hutchinson Cancer Center
Class: OTHER
Study ID: PSOC 1901
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Fred Hutchinson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH